|
The Pediatric Advanced Care Team (PACT) at Children’s Hospital Boston/Dana-Farber Cancer Institute was named a finalist for the 2009 Schwartz Center Compassionate Caregiver Award. The award recognizes the Massachusetts caregiver or team that best embodies the Schwartz Center’s mission to support and advance compassionate health care by relating and providing hope to patients and their families. Under the direction of Joanne Wolfe, MD, MPH, director of Pediatric Palliative Care, PACT was named one of five finalists from a field of more than 100 nominees.
The Harvard Catalyst recently awarded its second round of one-year, $50,000 Pilot Grants to researchers leading innovative, high-impact multidisciplinary projects. The Pilot program’s goal is to nurture clinical and translational researchers by giving them the financial means to develop preliminary data they need before applying for large-scale funding. Grants were awarded to many projects involving Children’s researchers.
For a complete list: childrenshospital.org/views
Children’s has been selected as a Leapfrog Top Children’s Hospital this year, placing us among a distinguished group of the highest performing hospitals in the country. The Leapfrog Group is an initiative driven by organizations that buy health care who are working to initiate breakthrough improvements in the safety, quality and affordability of health care for Americans. Institutions designated as Top Hospitals demonstrate an exceptional level of performance and serve as a model for other hospitals.
 |
In December, the NIH announced 13 new government-approved embryonic stem cell lines. The newly approved lines—11 of which were developed at Children’s—were derived from embryos donated by couples undergoing in-vitro fertilization, and all meet the NIH’s ethical standards.
With more lines available, and additional approvals expected soon, the pace of stem cell research is expected to pick up and, with it, a better understanding of human diseases and better therapies for treating them. Willy Lensch, PhD, a researcher in George Daley’s lab, wrote on Thrive, Children’s blog, about what this means to the field of stem cell research- and to him personally.
Dr. Lensch’s blog post: childrenshospitalblog.org
Children’s Division of Hematology/Oncology and Dana-Farber/Children’s Hospital Cancer Care are launching the Clinical and Translational Investigation Program (CTIP). The goal of CTIP is to enhance clinical research and integrate Hematology/Oncology’s clinical and translational infrastructure and cancer and blood research programs across both institutions. As part of this effort, Children’s hired two investigators:Carlos Rodriguez-Galindo, MD(pictured), formerly from St. Jude Children’s Research Hospital, was hired as co-director of CTIP and director of the Solid Tumor Program at DFCI. Wendy London, PhD, was hired as director of Biostatistics in Hem/Onc and co-director of CTIP.
CHB collaborated with Al Noor Hospital in Abu Dhabi to host their 5th International Conference. Drs. Verhave, Rhabar, Lehmann and Meara
lectured and chaired sessions throughout the three day conference, which focusing on Pediatrics in General Practice.
|
